Crohn's Disease: From Immune Dysregulation to Intestinal Damage.
This review explains how genetic, microbial, immune, and stromal factors interact to cause Crohn’s disease, which helps explain why treatments often need to target specific immune pathways or biologic mechanisms. Understanding these mechanisms can clarify why new targeted therapies are being developed.
Clinicians, IBD researchers, patients interested in the biology of Crohn’s disease and how that informs emerging treatments, and newly diagnosed patients seeking mechanistic background.
What To Know
This review synthesizes molecular and cellular mechanisms underlying Crohn’s disease, focusing on how genetic vulnerabilities, microbial imbalance, immune responses, and stromal activation drive inflammation and structural complications.
It highlights pathways and signaling networks implicated in disease progression and links mechanistic insights to current and emerging therapeutic strategies. The article appears to be an academic review (abstract-level content extracted) rather than new clinical trial results.
Key takeaways are mechanistic (immune, stromal, microbial, genetic) and may help clinicians and researchers contextualize how evolving therapies target specific pathways. It does not provide direct treatment recommendations for individual patients.
For patients, the review underscores that Crohn’s arises from multiple interacting factors and that research is exploring targeted therapies informed by these mechanisms.
Structured content depth is abstract: the curator note is grounded in the source-provided abstract and does not reflect a full-text review. This is a mechanistic review, not a clinical trial report; it summarizes current knowledge and therapeutic implications rather than presenting new trial outcomes.
